HIMS · Hims & Hers Health, Inc.

Direct-to-consumer telehealth: subscriptions for hair, skin, weight loss and mental health

Risiko 8/10 · HIGH RISK · regulatory-fueled growth · $27.71 ▼ 0.40%🤖Von KI geschrieben

Stand der Zahlen: 07.09.2026 · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

• Price $27.71
• Market cap $6.5B
• P/E (ttm) n/a
• Div yield none
• 52-wk range $13.74 – $65.30
• Meme rank #18

Wichtigste Risiken

• Regulatory clampdown on compounded GLP-1 weight-loss drugs (Shareholders) — EXTREME
• Litigation from branded GLP-1 makers (Shareholders) — HIGH
• Margin reset as compounding pricing advantage erodes (Shareholders) — HIGH
• Treatment continuity if compounded supply is halted (Customers) — HIGH

Fazit

High-growth telehealth where one regulatory decision on compounded GLP-1s can reprice the whole model overnight.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.